Cargando…
Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy
BACKGROUND: We have previously shown that HCC patients and healthy subjects are equally responsive to a RNAdjuvant(®), a novel TLR-7/8/RIG-I agonist based on noncoding RNA developed by CureVac, by an ex vivo evaluation. However, the immunological effect of adjuvants on immune cells from cancer patie...
Autores principales: | Mauriello, Angela, Manolio, Carmen, Cavalluzzo, Beatrice, Avallone, Antonio, Borrelli, Marco, Morabito, Alessandro, Iovine, Emanuele, Chambery, Angela, Russo, Rosita, Tornesello, Maria Lina, Buonaguro, Franco M., Tagliamonte, Maria, Buonaguro, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977281/ https://www.ncbi.nlm.nih.gov/pubmed/31973714 http://dx.doi.org/10.1186/s12967-020-02218-x |
Ejemplares similares
-
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022) -
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021) -
Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023) -
Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021) -
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)